HealthEquity, Inc. (NASDAQ:HQY) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of HealthEquity, Inc. (NASDAQ:HQY) have been assigned an average rating of “Moderate Buy” from the thirteen analysts that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and eleven have issued a buy rating on the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $110.9286.

A number of equities analysts have weighed in on HQY shares. Wells Fargo & Company set a $111.00 target price on HealthEquity in a research report on Monday, June 1st. Citigroup reaffirmed a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st. Citizens Jmp lifted their price target on shares of HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research note on Monday, June 1st. KeyCorp reissued an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. Finally, Barrington Research restated an “outperform” rating and set a $110.00 price objective on shares of HealthEquity in a research report on Friday, May 22nd.

Insiders Place Their Bets

In other HealthEquity news, EVP Delano Ladd sold 7,500 shares of the business’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $675,000.00. Following the completion of the sale, the executive vice president directly owned 91,141 shares in the company, valued at approximately $8,202,690. The trade was a 7.60% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 2,354 shares of the stock in a transaction on Friday, July 10th. The shares were sold at an average price of $95.00, for a total value of $223,630.00. Following the transaction, the executive vice president directly owned 52,244 shares in the company, valued at $4,963,180. The trade was a 4.31% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 17,905 shares of company stock valued at $1,651,280. Company insiders own 1.60% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of HQY. William Blair Investment Management LLC bought a new position in HealthEquity in the fourth quarter worth approximately $169,956,000. Wasatch Advisors LP grew its position in shares of HealthEquity by 10.5% during the 2nd quarter. Wasatch Advisors LP now owns 7,960,735 shares of the company’s stock valued at $719,014,000 after acquiring an additional 757,801 shares during the period. Norges Bank bought a new stake in shares of HealthEquity during the 4th quarter valued at $66,927,000. AQR Capital Management LLC increased its stake in shares of HealthEquity by 148.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after purchasing an additional 661,795 shares in the last quarter. Finally, Millennium Management LLC increased its stake in shares of HealthEquity by 151.5% in the 4th quarter. Millennium Management LLC now owns 951,563 shares of the company’s stock worth $87,173,000 after purchasing an additional 573,283 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

HealthEquity stock opened at $100.61 on Monday. HealthEquity has a 12 month low of $72.76 and a 12 month high of $105.96. The stock has a fifty day simple moving average of $91.74 and a two-hundred day simple moving average of $85.13. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. The firm has a market cap of $8.41 billion, a price-to-earnings ratio of 37.68, a PEG ratio of 1.69 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The firm had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. The firm’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities analysts predict that HealthEquity will post 3.92 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.